Table 2 Preoperative, one year and two years follow-up values for IKDC and KOOS overall and subcategories
Pre-Operative | 1 Year Follow-Up | 2 Years Follow-Up | |||||
|---|---|---|---|---|---|---|---|
Mean ± SD (min-max) | Mean ± SD (min-max) | Improvement (MD) Vs Pre-Op | P value | Mean ± SD (min-max) | Improvement (MD) Vs Pre-Op | P value | |
IKDC | 40.3 ± 10.3 (19.5–56.3) | 66.6 ± 8.6 (37.9–95.4) | 26.4 | < 0.0001 | 66.8 ± 17.2 (19.5–89.7) | 26.5 | < 0.0001 |
KOOS Overall | 48.3 ± 13.9 (23.2–73.1) | 77.8 ± 17.1 (52.4–96.3) | 29.5 | < 0.0001 | 77.3 ± 23.8 (24.4–97.6) | 29.0 | < 0.0001 |
KOOS SS | 53.6 ± 17.9 (7.1–85.7) | 78.8 ± 11.9 (53.6–92.9) | 25.3 | < 0.0001 | 82.0 ± 22.5 (35.7–100.0) | 28.4 | < 0.0001 |
KOOS P | 41.6 ± 15.0 (25.0–80.6) | 77.9 ± 26.4 (5.0–94.4) | 36.3 | < 0.0001 | 77.8 ± 26.5 (5.0–97.2) | 35.9 | < 0.0001 |
KOOS FD | 54.6 ± 13.5 (26.5–75.0) | 81.8 ± 29.5 (60.3–98.5) | 27.1 | < 0.0001 | 82.1 ± 29.0 (25.0–100.0) | 27.4 | < 0.0001 |
KOOS FSR | 31.4 ± 15.5 (0.0.55.0) | 63.1 ± 25.3 (25.0–95.0) | 31.8 | < 0.0001 | 54.0 ± 28.4 (0.0–95.0) | 22.7 | < 0.0001 |
KOOS QoL | 47.3 ± 14.2 (25.0–75.0) | 69.7 ± 36.3 (37.5–100.0) | 22.3 | < 0.0001 | 68.6 ± 35.9 (6.3–100.0) | 21.5 | < 0.0001 |